RANI CEO Imran Talat Withholds 7,928 Shares for Taxes

What Happened

• Imran Talat, Chief Executive Officer of Rani Therapeutics Holdings, had 7,928 shares withheld and surrendered to the company to satisfy tax withholding obligations related to the settlement and release of restricted stock units. The shares were valued at $0.76 each, totaling $6,019. This is a routine tax-withholding disposition rather than an open-market sale or purchase.

Key Details

• Transaction date: 2026-09-27
• Price per share: $0.76; Total value: $6,019
• Transaction code: F (shares withheld to satisfy tax withholding obligations)
• Footnote: F1 — shares were withheld by and surrendered to the issuer to satisfy tax withholding in connection with RSU settlement/release
• Shares owned after transaction: Not specified in the provided filing excerpt
• Filing timeliness: Report filed 2026-09-29 for a 2026-09-27 transaction (appears timely; no late-file indicator)

Context

• This was a tax-withholding event tied to RSU vesting (a common, administrative disposition). It does not represent an open-market sale driven by a decision to liquidate shares, nor does it indicate a purchase/positive insider accumulation.